Literature DB >> 4400576

Human pharmacology of indoramin.

D J Coltart, J D Lockhart, R B Royds, P Turner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4400576      PMCID： PMC1665879     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Some central and peripheral effects of meclastine, a new antihistaminic drug, in man.

Authors:  A Hedges; W P Maclay; A J Newman-Taylor; P Turner
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Mar-Apr

2.  Critical flicker frequency and centrally-acting drugs.

Authors:  P Turner
Journal:  Br J Ophthalmol       Date:  1968-03       Impact factor: 4.638

3.  Ephedrine mydriasis in hypertension and the response to treatment.

Authors:  J M Sneddon; P Turner
Journal:  Clin Pharmacol Ther       Date:  1969 Jan-Feb       Impact factor: 6.875
  3 in total
  4 in total

1.  The effect of indoramin on peripheral blood flow.

Authors:  R B Royds; J D Lockhart
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

2.  Effect of indoramin on finger blood flow in vasospastic patients.

Authors:  D L Clement
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

Review 3.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

4.  The human pupil as a model for clinical pharmacological investigations.

Authors:  P Turner
Journal:  J R Coll Physicians Lond       Date:  1975-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.